Stocktoria
C4 Therapeutics, Inc. CCCC
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-10-02
Chart by TradingView
3/9
Piotroski F — financial health
-2.12
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $35.9M | $35.6M | $20.8M | $31.1M | $45.8M |
| Operating income | -$115.2M | -$119.6M | -$139.0M | -$129.5M | -$82.1M |
| Net income | -$105.0M | -$105.3M | -$132.5M | -$128.2M | -$83.9M |
| Operating cash flow | -$98.7M | -$65.2M | -$106.8M | -$105.9M | -$87.0M |
| Free cash flow | -$99.3M | -$65.3M | -$108.5M | -$111.4M | -$88.2M |
| Total assets | $359.1M | $349.6M | $376.5M | $430.8M | $506.8M |
| Total liabilities | $102.5M | $133.6M | $130.3M | $141.6M | $117.2M |
| Shareholders' equity | $256.6M | $216.0M | $246.1M | $289.2M | $389.6M |
| Ratios | |||||
| Operating margin | -320.5% | -336.1% | -669.8% | -416.6% | -179.4% |
| Net margin | -292.1% | -296.0% | -638.3% | -412.2% | -183.2% |
| FCF margin | -276.2% | -183.6% | -523.0% | -358.4% | -192.7% |
| Return on assets | -29.2% | -30.1% | -35.2% | -29.8% | -16.6% |
| Return on equity | -40.9% | -48.8% | -53.8% | -44.3% | -21.5% |
| Debt / equity | — | — | 0.00× | 0.04× | 0.03× |
| Current ratio | 7.81 | 5.71 | 6.34 | 6.46 | 6.36 |
| Revenue growth | 1.0% | 71.4% | -33.3% | -32.1% | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 2,461,815 | $6.5M |
| Point72 Asset Management, L.P. | 169,096 | $444,722 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -2.12 (distress)
- Working capital / assets 0.627
- Retained earnings / assets -2.057
- EBIT / assets -0.321
- Equity / liabilities 2.504
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001662579 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.